Methods and Uses of High Thymoquinone and Thymohydroquinone Essential Oil of Monarda
A method for cultivating Monarda for production of thymoquinone and thymohydroquinone includes seeding or plug planting Monarda fistulosa and/or Monarda didyma plants. The method of cultivation results in increased production of essential oils including thymoquinone and thymohydroquinone which are believed to have anti-inflammatory effects relative to a number of health-related conditions. The invention describes ways to deliver the thymoquinone and/or thymohydroquinone rich oil to a human or animal, using a variety of therapeutic delivery methods, for the prevention or reduction of inflammation associated with a disease state.
1 . A therapeutic oil comprising essential oil of monarda, said essential oil of monarda including between about 1% and about 40% thymoquinone and thymohydroquinone combined.
2 . A composition comprising the therapeutic oil of claim 1 .
3 . The composition of claim 2 further comprising at least one of a group consisting of: a second oil, a lotion, a gel, a cream, a paste, an additional therapeutic adjuvant, a food additive, a flavor.
4 . The therapeutic oil of claim 1 , said oil contained in a gel cap.
5 . The therapeutic oil of claim 1 , said oil delivered by at least one delivery trajectory selected from the group consisting of: a lotion, a cream, a gel, a transdermal patch, a spray, an injectable adjuvant, an intravenous solution.
6 . A method of delivering the therapeutic oil of claim 1 to a mammal, said method selected from a group consisting of: transdermal application, pulmonary delivery, oral ingestion, intravenous drip, subcutaneous injection, subcutaneous implant, and medical pump.
7 . The composition of claim 2 , said composition comprising a second oil.
8 . The method of claim 6 wherein pulmonary delivery comprises delivery of the therapeutic oil by one of a group consisting of: an inhaler, an inhalant, a diffuser.
9 . The therapeutic oil of claim 1 , said oil obtained by steam distillation of a plurality of leaves and seed heads harvested from Monarda fistulosa plants grown from plugs planted between about 24,000 and 60,000 plants per acre.
10 . A method of managing inflammation in a mammal, said method comprising using essential oil of monarda comprising between about 1% and 40% thymoquinone and thymohydroquinone combined.
11 . The method of claim 10 comprising administering an amount of said essential oil to a human by one from the following methods: transdermal, subcutaneous, intravenous, inhalation, pulmonary delivery, oral ingestion.
12 . The method of claim 11 wherein administration is transdermal comprising applying the essential oil to a portion of the sole of a human foot.
13 . The method of claim 12 wherein the essential oil is combined with at least one of the following prior to transdermal application: a second oil, lotion, cream, gel.
14 . The method of claim 11 wherein administration is by oral ingestion comprising ingesting a gel cap containing a composition of the essential oil of Monarda.
15 . The method of claim 11 wherein administration is by inhalation comprising diffusing said essential oil prior to inhalation.
16 . The method of claim 10 wherein the inflammation is caused by arthritis.
17 . The method of claim 10 wherein the inflammation is caused by cancer.
18 . The method of claim 10 wherein the inflammation is caused by a viral infection.
19 . The method of claim 10 wherein the inflammation is caused by a microbial infection.
20 . The method of claim 10 wherein a symptom of the inflammation is respiratory.
21 . The method of claim 10 wherein a symptom of the inflammation is tumor growth.
22 . The method of claim 10 wherein a symptom of the inflammation is related to diet, lack of exercise and genetics.
23 . The method of claim 10 wherein the inflammation is caused by cancer.
24 . The method of claim 23 wherein the cancer is leukemia.
25 . The composition of claim 2 , said composition contained in a gel cap.
26 . The composition of claim 2 , said composition delivered by at least one delivery trajectory selected from the group consisting of: a lotion, a cream, a gel, a transdermal patch, a spray, an injectable adjuvant, an intravenous solution.
27 . A method of delivering the composition of claim 2 to a human said method selected from a group consisting of: transdermal application, pulmonary delivery, oral ingestion, intravenous drip, subcutaneous injection, subcutaneous implant, and medical pump.
28 . A method of managing inflammation in a human comprising using the composition of claim 2 .
29 . The method of claim 6 wherein said mammal includes humans and companion animals.